Results 231 to 240 of about 244,280 (409)

Am J Clin Nutr [PDF]

open access: yes
BackgroundFood fortification is one approach for addressing anemia, but information on program effectiveness is limited.ObjectiveWe evaluated the impact of Costa Rica\u2019s fortification program on anemia in women aged 15\u201345 y and children aged 1 ...

core  

Arbuscular mycorrhizal fungal inoculation increases the bioavailability of zinc and iron in wheat grain

open access: yesPLANTS, PEOPLE, PLANET, EarlyView.
Bread wheat is an important crop that supplies calories and nutrients to the global population. Enhancing the concentrations and bioavailability of essential micronutrients in wheat is crucial for human nutrition, and we investigated whether arbuscular mycorrhizal (AM) fungi can contribute to the biofortification of wheat.
Thi Diem Nguyen   +5 more
wiley   +1 more source

The Effect of Iron Deficiency Anemia on the Morphology-Voltage-P Wave Duration (MVP) Risk Score. [PDF]

open access: yesAnn Noninvasive Electrocardiol
Yildiz G   +4 more
europepmc   +1 more source

Prospective of indigenous African wild food plants in alleviation of the severe iron deficiency anaemia in Sub‐Saharan Africa

open access: yesPLANTS, PEOPLE, PLANET, EarlyView.
Iron deficiency anaemia remains a major public health challenge in Sub‐Saharan Africa, where population growth, displacement and limited resources heighten nutritional insecurity. We compiled a list of indigenous African underutilized wild food plants and examined their potential for addressing micronutrient deficiencies.
Eltayb Abdellatef   +2 more
wiley   +1 more source

Challenges in the diagnosis of iron deficiency anemia in aged people

open access: diamond, 2017
Niele Silva de Moraes   +1 more
openalex   +1 more source

Talazoparib Formulation Bridging in Cancer Patients—Challenges and the Critical Role of Model‐Informed Drug Development in Approval Despite Failed Bioequivalence

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Talazoparib is a poly(ADP‐ribose) polymerase inhibitor approved for the treatment of breast and prostate cancer. Commercialization of a soft gelatin capsule (SGC) formulation developed post‐approval required a bioequivalence (BE) and food effect (FE) study to bridge SGC with the initial commercial hard capsule (HC) formulation. Study execution
Diane Wang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy